awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35591889-87691C22-C1BA-4B54-A375-7EC917957192
Q35591889-87691C22-C1BA-4B54-A375-7EC917957192
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35591889-87691C22-C1BA-4B54-A375-7EC917957192
A systematic review of the efficacy and safety experience reported for sorafenib in advanced renal cell carcinoma (RCC) in the post-approval setting.
P2860
Q35591889-87691C22-C1BA-4B54-A375-7EC917957192
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35591889-87691C22-C1BA-4B54-A375-7EC917957192
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
63e087bcd3c4f7e3b8adbeebd5aca639eca45a17
P2860
Efficacy of sorafenib in advanced renal cell carcinoma independent of prior treatment, histology or prognostic group.